OLMA – olema pharmaceuticals, inc. (US:NASDAQ)

News

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Olema Pharmaceuticals (OLMA) is now covered by Wolfe Research. They set a "peer perform" rating on the stock.
Jim Cramer on Olema Pharmaceuticals: “Too Risky for Me” [Yahoo! Finance]
Olema Shelf Registration Raises Questions On Dilution And Funding Flexibility [Yahoo! Finance]
Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential? [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com